PPV and NPV at deployment prevalence

Local prevalence adjustment.

Who judgesClinician judgement and real-world outcomes
EvidenceGrade E4
Product typeImagingID I2

What ppv and npv at deployment prevalence means

Local prevalence adjustment.

Why it matters. Predictive values depend on how common the condition is where you work.

Example, illustrative

A strong model has a low PPV in a low-prevalence screening clinic.

How to measure it

01

Gather local scans

Use scans from your own scanners and protocols.

02

Adjudicate labels

Radiologists agree the reference reading.

03

Test across sites and groups

Check scanners, sites and patient groups separately.

04

Check calibration

Compare predicted and observed rates.

Watch out for

Performance at the vendor's test site often doesn't hold at yours.

What a good report shows

Local sensitivity and specificity with subgroup tables, external-site results and calibration.

Report local performance with radiologist-adjudicated labels, external sites, subgroup results and calibration, against a cleared comparator.

Reviewed by the Precision research team.

How strong is the evidence

E4 · Recalled, not verified. Recalled from background knowledge and not verified. Treat it as a lead for investigation, not a finding.

What the sources say

E4.

  • Clinician judgement. Needs a clinician to judge or label, because the answer depends on clinical meaning.
  • Real-world outcomes. Needs outcome data from live use, such as time saved, burnout or patient results.

Found something out of date? Write to hello@precision.example.

Quick answers

What is ppv and npv at deployment prevalence in healthcare AI?

Local prevalence adjustment. It sits in the imaging and diagnostics group.

Why does ppv and npv at deployment prevalence matter?

Predictive values depend on how common the condition is where you work. A strong model has a low PPV in a low-prevalence screening clinic.

How is ppv and npv at deployment prevalence measured?

Gather local scans, then Adjudicate labels, then Test across sites and groups, then Check calibration. Report local performance with radiologist-adjudicated labels, external sites, subgroup results and calibration, against a cleared comparator.

What should I watch out for with ppv and npv at deployment prevalence?

Performance at the vendor's test site often doesn't hold at yours. A good report gives: local sensitivity and specificity with subgroup tables, external-site results and calibration.

Can ppv and npv at deployment prevalence be automated?

Only in part. It needs clinician judgement and real-world outcomes. Software can screen, but a clinician must judge the cases that matter.

Measure ppv and npv at deployment prevalence on your own data